Desjardins, A., Vredenburgh, J. J., Peters, K. B., Friedman, A. H., Gururangan, S., Friedman, H., & Reardon, D. A. (2009). SUNITINIB PLUS IRINOTECAN FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE I TRIAL. In NEURO-ONCOLOGY (Vol. 11, pp. 633–634).

Desjardins, Annick, James J. Vredenburgh, Katherine B. Peters, Allan H. Friedman, Sridharan Gururangan, Henry Friedman, and David A. Reardon. “SUNITINIB PLUS IRINOTECAN FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE I TRIAL.” In NEURO-ONCOLOGY, 11:633–34, 2009.

Desjardins A, Vredenburgh JJ, Peters KB, Friedman AH, Gururangan S, Friedman H, et al. SUNITINIB PLUS IRINOTECAN FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE I TRIAL. In: NEURO-ONCOLOGY. 2009. p. 633–4.

Desjardins, Annick, et al. “SUNITINIB PLUS IRINOTECAN FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE I TRIAL.” NEURO-ONCOLOGY, vol. 11, no. 5, 2009, pp. 633–34.

Desjardins A, Vredenburgh JJ, Peters KB, Friedman AH, Gururangan S, Friedman H, Reardon DA. SUNITINIB PLUS IRINOTECAN FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE I TRIAL. NEURO-ONCOLOGY. 2009. p. 633–634.